PC: Jewel Samad/Getty

NEW DELHI—As of 6 p.m. on Jan. 20, the fifth day of its COVID-19 vaccine rollout, India had inoculated a total of 786, 842 people. Over the next few weeks, it aims to inoculate 30 million health and other frontline workers, and by mid-August it plans to have vaccinated another 300 million people with the help of two vaccines—Covishield by Oxford University/AstraZeneca being made in India by the Pune-based Serum Institute, the world’s largest vaccine manufacturer, and Covaxin, a government-backed, homegrown vaccine from Bharat Biotech.

“This scale of vaccination campaign has never been attempted in history and this shows India’s capability,” Prime Minister Narendra Modi had said while opening the vaccine rollout on Jan. 16.

READ MORE

Leave a Reply

Your email address will not be published. Required fields are marked *